Flywheel Exchange

The company operates on a software-as-a-service (SaaS) business model, generating revenue through subscriptions and data management fees, with tiered pricing based on usage. Flywheel serves a diverse clientele that includes pharmaceutical and biotech companies, academic medical centers, life sciences researchers, healthcare providers, and payers. Its platform is engineered to ingest, curate, and manage large-scale medical imaging and associated data, preparing it for analysis and artificial intelligence development. The core platform streamlines research workflows by automating data pre-processing, enabling secure collaboration across multiple sites, and ensuring regulatory compliance with standards like HIPAA and GDPR.

Flywheel's product suite includes features for data import, automated curation, image processing, and machine learning workflows. It offers open APIs and SDKs for Python, R, and MatLab to allow for custom tool integration. A key component is the 'Flywheel Gear Exchange,' a library of plug-in applications that automate tasks such as metadata extraction, quality assurance, and running full analytic pipelines. In 2021, Flywheel acquired Radiologics, a provider of software and services for imaging-based clinical trials, to enhance its workflow solutions and expand its global network. The company has secured significant funding, including a $54 million Series D round in June 2023, co-led by Novalis LifeSciences and NVentures (NVIDIA's venture arm), with participation from Microsoft and other investors.